BUY Anthem Biosciences Limited — Ashish Chaturmohta, JM Financial
byAshish Chaturmohta, JM FinancialHorizon: 1 year8 Oct 2026via CNBC Awaaz.
Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.
AI Assessment
Automated market context for this BUY call — facts from public sources, machine-classified. Not investment advice.
Long-term trend bullish — 200-day average rising over the past quarter
Technicals · trend·8 Oct · yesterday
2 other SEBI-registered advisors have active long-term BUY calls on this stock
Advisor consensus · same horizon·21 Aug · 2mo ago
Nothing found in this tip’s window yet.
Nothing found in this tip’s window yet.
Factor classifications are AI-generated from exchange filings, verified news feeds and market data — they can be wrong or incomplete, and are not attributed to the issuing analyst. Verify every factor via its linked original before acting. This is not investment advice.
Other calls on Anthem Biosciences
- BUY — Siddharth Rai Mangala7 Oct 2026 · Same day · target ₹930 · Expired
- BUY — Kush Bohra2 Sept 2026 · ~2 weeks · target ₹980 · Expired
- BUY — Ashish Bahety, Profitmart Securities2 Sept 2026 · ~2 weeks · target ₹990 · SL hit
- BUY — Ashish Chaturmohta, JM Financial2 Sept 2026 · ~2 weeks · target ₹1,040 · Expired
- BUY — IDBI Capital1 Sept 2026 · ~2 weeks · target ₹958 · Target hit
More from Ashish Chaturmohta, JM Financial
- BUY Navin Fluorine International8 Oct 2026 · ~1 year · target ₹10,000 · Active
- BUY Avalon Technologies7 Oct 2026 · ~2 weeks · target ₹2,800 · SL hit
- BUY INOX India1 Oct 2026 · ~1 year · target ₹2,500 · SL hit
- BUY Aegis Vopak Terminals30 Sept 2026 · ~2 weeks · target ₹330 · Active
- BUY Sona BLW Precision Forgings30 Sept 2026 · ~1 year · target ₹950 · Active

